Skip to content
PICO Portalanswers from OpenAlex

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy

PaperCitations, authors & open-access status

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy is a paper indexed in PICO Portal from OpenAlex.

How many citations does GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy have?

PICO Portalcitation count

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy has 28 citations in the OpenAlex counts PICO Portal stores.

When was GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy published?

PICO Portalyear

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy has 2021 year in the PICO Portal index.

What is the open-access status of GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy?

PICO Portaloa status

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy has green oa status in the PICO Portal index.

What is the DOI of GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy?

PICO Portaldoi

The DOI for GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy is on the source record.

What is the PMID of GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy?

PICO Portalpmid

The PMID for GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy is on the source record.

What is the OpenAlex record for GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy?

PICO Portalopenalex

The OpenAlex for GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial